Page last updated: 2024-08-16

phenylpropanolamine and Schizophrenia

phenylpropanolamine has been researched along with Schizophrenia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borovicka, MC; Fuller, MA; Jaskiw, GE; Konicki, PE; Steele, VM; White, JC1

Trials

1 trial(s) available for phenylpropanolamine and Schizophrenia

ArticleYear
Phenylpropanolamine appears not to promote weight loss in patients with schizophrenia who have gained weight during clozapine treatment.
    The Journal of clinical psychiatry, 2002, Volume: 63, Issue:4

    Topics: Adult; Ambulatory Care; Antipsychotic Agents; Appetite Depressants; Clozapine; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Obesity; Phenylpropanolamine; Pilot Projects; Placebos; Psychiatric Status Rating Scales; Research Design; Schizophrenia; Treatment Outcome; Weight Gain; Weight Loss

2002